SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
78 hedge funds and large institutions have $75M invested in Sorrento Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
66% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 29
Holders
78
Holding in Top 10
–
Calls
$313K
Puts
$270K
Top Buyers
| 1 | +$4.55M | |
| 2 | +$1.71M | |
| 3 | +$1.33M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.28M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$594K |
Top Sellers
| 1 | -$6.02M | |
| 2 | -$4.34M | |
| 3 | -$2.45M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.18M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |